| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $653.3M | +10.7% |
| Cost of Revenue | $162.0M | +10.3% |
| Gross Profit | $491.4M | +10.9% |
| R&D Expense | $101.0M | -2.2% |
| SG&A Expense | $121.8M | +70.3% |
| Operating Income | $18.5M | +29.2% |
| Pre-tax Income | $124.7M | +106.1% |
| Income Tax | -$43.1M | -3070.1% |
| Net Income | $161.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $885.9M | +226.8% |
| Accounts Receivable | $178.1M | +3.8% |
| Current Assets | $1.09B | -22.4% |
| Total Assets | $1.83B | -13.1% |
| Current Liabilities | $422.2M | -34.3% |
| Total Liabilities | $1.34B | -25.9% |
| Stockholders' Equity | $446.7M | +71.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $190.8M | +50.7% |
| Capital Expenditures | $2.1M | -64.3% |
| Investing Cash Flow | $924.4M | +1579.5% |
| Financing Cash Flow | -$500.1M | -8237.7% |
| Free Cash Flow | $188.7M | +56.4% |
| +205.1% |
| EPS (Basic) | $2.59 | +197.7% |
| EPS (Diluted) | $1.45 | +79.0% |